Product Information

ARFORMOTEROL 15 MCG/2 ML SOLN is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.6429 per ML under NDC 00093595506. Its NADAC has been published 240 times since Jan 19, 2022.

FDA first approved this application on Nov 9, 2021.

The High Outlier badge above means this manufacturer's average price in the Arformoterol tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ARFORMOTEROL 15 MCG/2 ML SOLN

Arformoterol tartrate
$0.6429per ML
High Outlier

Strength

15 ug/2mL

NDC

00093595506

Classification

Generic

Dosage Form

SOLUTION

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Active Ingredients

ARFORMOTEROL TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA200293

FDA Approved

11/9/2021

On Market Since

12/6/2021

Pharmacological Classes

Adrenergic beta2-Agonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has been published 240 times since Jan 19, 2022, and over the history we have for it it has declined 79.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6429 per ML
All-time high$3.3645 (May 11, 2022)
All-time low$0.6429 (Aug 19, 2026)
52-week high$0.7666
52-week low$0.6429
Median price$1.2282
Average price$1.4260
Largest weekly change+40.5% (Nov 22, 2023)
Weeks tracked240
Tracking sinceJan 19, 2022

Price History

1W

N/A

1M

N/A

3M

-2.8%

6M

-4.8%

1Y

-9.3%

3Y

-53.2%

5Y

N/A

All

-79.1%

Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ARFORMOTEROL 15 MCG/2 ML SOLN?

The current National Average Drug Acquisition Cost (NADAC) for ARFORMOTEROL 15 MCG/2 ML SOLN, manufactured by Teva Pharmaceuticals USA Inc., is $0.6429 per ML (NDC 00093595506), effective Aug 19, 2026.

How has the price of ARFORMOTEROL 15 MCG/2 ML SOLN changed over time?

Over the history we have for it, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has declined 79.1%. It has been tracked across 240 weekly CMS publications since Jan 19, 2022.

What are the highest and lowest recorded NADAC prices for ARFORMOTEROL 15 MCG/2 ML SOLN?

Since Jan 19, 2022, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has ranged from a low of $0.6429 (Aug 19, 2026) to a high of $3.3645 (May 11, 2022), with a median of $1.2282 per ML.

Are there cheaper alternatives to ARFORMOTEROL 15 MCG/2 ML SOLN?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARFORMOTEROL 15 MCG/2 ML SOLN, is $0.6145 per ML — about 4% below ARFORMOTEROL 15 MCG/2 ML SOLN.

Who manufactures ARFORMOTEROL 15 MCG/2 ML SOLN?

ARFORMOTEROL 15 MCG/2 ML SOLN (NDC 00093595506) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.